Ark Genomic Revolution UCITS ETF (SWX:ARKG)
Switzerland · Delayed Price · Currency is CHF 5.14
-0.40 (-7.19%)
At close: Jun 5, 2026
SWX:ARKG Holdings Information
SWX:ARKG is an equity ETF with a total of 32 individual holdings. The top holdings are Twist Bioscience stock at 9.59%, CRISPR Therapeutics AG at 7.52%, Tempus AI at 7.26%, Personalis at 6.22%, and Absci at 5.87%.
Total Holdings
32
Top 10 Percentage
59.28%
Asset Class
Equity
ETF Category
Theme
Assets
46.35M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 9.59% |
| 2 | CRSP | CRISPR Therapeutics AG | 7.52% |
| 3 | TEM | Tempus AI, Inc. | 7.26% |
| 4 | PSNL | Personalis, Inc. | 6.22% |
| 5 | ABSI | Absci Corporation | 5.87% |
| 6 | TXG | 10x Genomics, Inc. | 4.93% |
| 7 | ILMN | Illumina, Inc. | 4.85% |
| 8 | BEAM | Beam Therapeutics Inc. | 4.72% |
| 9 | NTLA | Intellia Therapeutics, Inc. | 4.19% |
| 10 | NTRA | Natera, Inc. | 4.12% |
| 11 | RXRX | Recursion Pharmaceuticals, Inc. | 3.40% |
| 12 | CDNA | CareDx, Inc. | 3.35% |
| 13 | CMPS | COMPASS Pathways plc | 3.34% |
| 14 | VCYT | Veracyte, Inc. | 3.25% |
| 15 | GH | Guardant Health, Inc. | 3.16% |
| 16 | ADPT | Adaptive Biotechnologies Corporation | 2.04% |
| 17 | SDGR | Schrödinger, Inc. | 2.01% |
| 18 | NRIX | Nurix Therapeutics, Inc. | 2.01% |
| 19 | BFLY | Butterfly Network, Inc. | 1.93% |
| 20 | WGS | GeneDx Holdings Corp. | 1.78% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.74% |
| 22 | ATAI | AtaiBeckley Inc. | 1.66% |
| 23 | LLY | Eli Lilly and Company | 1.54% |
| 24 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.48% |
| 25 | CERS | Cerus Corporation | 1.40% |
As of Jun 4, 2026